Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential. [PDF]
FASEB JVirk UY +5 more
europepmc +1 more source
CAR-T cell therapy for solid tumors: antigen landscape, biological barriers, and engineering strategies for clinical translation. [PDF]
Front ImmunolNiu Q +5 more
europepmc +1 more source
Recent advances in molecular mechanisms to improve the efficacy of CAR-T cell therapy for viral diseases, cancer, and autoimmune diseases. [PDF]
Stem Cell Res TherMarei HE +3 more
europepmc +1 more source
Engineering autoimmune disease models using organoids: Harnessing microenvironmental engineering for precision medicine and immunological recapitulation. [PDF]
Bioeng Transl MedLee CJ, Kim Y, Kim M, Rim YA, Ju JH.
europepmc +1 more source
Engineering immune cell engagers: From molecular constructs to biomaterial platforms. [PDF]
Mater Today BioPark HW, Kim S.
europepmc +1 more source
Immune Evasion Strategies of Human Poxviruses: A Roadmap for Engineering Low-Immunogenic CAR-Based and iPSC-Derived Cell Products. [PDF]
CellsAntonov DO +9 more
europepmc +1 more source
Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers. [PDF]
NeoplasiaQu Q, Xiao J, Zhao B, Gu P.
europepmc +1 more source
Clinical trial landscape and translational prospects of natural killer cell-based immunotherapy: an analysis based on the INFORMA database. [PDF]
J Immunother CancerSun H, Zhang Y, Yuan Y, Liu D, Qiao J.
europepmc +1 more source
Advancing T Cell Engagers in Multiple Myeloma: Structural Design and Clinical Optimization to Address Current Limitations. [PDF]
Drug Des Devel TherCai L +8 more
europepmc +1 more source
Chemokines as regulators of CAR-T cell trafficking, function, and context-dependent tumor cell death. [PDF]
Front ImmunolLevchuk K +6 more
europepmc +1 more source